Background Treatment success of H. pylori eradication therapy has declined worldwide
largely because of increased antimicrobial resistance. New therapeutic approaches are …

Results: Following furazolidone-based first-line therapy, H. pylori eradication rates were
75.7% and 79.6% at ITT and PP analysis, respectively (P< 0.001). The overall incidence of …

Background/aims: Furazolidone has been introduced as an effective drug against
Helicobacter pylori infection in Iran, but intolerable side effects may limit its use. The aim of …

Background: Furazolidone‐based regimens for the eradication of Helicobacter pylori are low
cost and effective. Unfortunately, the usual dose of furazolidone is not tolerable in many …

Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori) treatment failures.
Because the resistance rate of H. pylori to furazolidone is low, we aimed to assess the …

Abstract Background and Aim: Furazolidone‐based regimens for the eradication of
Helicobacter pylori are low cost and effective although less tolerable. Our aim was to …

BACKGROUND Furazolidone has been used as an alternative for clarithromycin or
metronidazole in Helicobacterpylori (H. pylori) eradication regimens. In Iran, 14-day …

Aim: To study the efficacy and side effects of furazolidone when given for 1 week in
combination with bismuth subcitrate, amoxicillin, and omeprazole. Patients and Methods …

Background: Furazolidone has been effective against Helicobacter pylori in Iran, with no
resistance, but with intolerable side effects in the second week. One-week regimens have …

Abstract Background The efficacy of Helicobacter pylori (H. pylori) eradication has steadily
declined, primarily because of antibiotic resistance. This study aimed to evaluate the efficacy …